Repligen Co. (NASDAQ: RGEN) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Repligen Co. (NASDAQ: RGEN) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "hold" rating and a $165.00 price target on the stock.
Repligen Co. (NASDAQ: RGEN) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "hold" rating and a $165.00 price target on the stock.
Repligen (RGEN) Up 3.2% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
Repligen Announces Publication of the Company's 2023 Corporate Sustainability Report [Yahoo! Finance]